. Author manuscript; available in PMC: 2022 Feb 16.

Published in final edited form as: J Am Coll Cardiol. 2021 Feb 16;77(6):713–724. doi: 10.1016/j.jacc.2020.11.066

Table 4.

TR progression and ≥moderate TR at 2 years by recurrent mitral regurgitation and presence of pacemaker/ICD lead at 1- and 2-years follow-up.

2 Year Outcome	≥Moderate MR at 1 Year		P- value	≥Moderate MR at 2 Years^*		P- value
2 Year Outcome	Yes	No	P- value	Yes	No	P- value
TR Progression	8/60 (13.3)	11/251 (4.4)	0.02	6/65 (9.2)^*	12/258 (4.7)	0.22
≥Moderate TR	12/58 (20.7)	22/251 (8.8)	0.009	13/65 (20)	24/258 (9.3)	0.02

2 Year Outcome	Pacemaker or ICD by 1 Year		P- value	Pacemaker or ICD by 2 Years		P- value
2 Year Outcome	Yes	No	P- value	Yes	No	P- value
TR Progression	6/79 (7.6)	14/246 (5.7)	0.59	7/87 (8.0)	13/238 (5.5)	0.39
≥Moderate TR	15/78 (19.2)	22/245 (9.0)	0.01	16/85 (18.8)	21/238 (8.8)	0.01

2 patients that had MV surgery in between year 1 and 2 are excluded from the denominator.

ICD, implantable cardioverter-defibrillator; MR, mitral regurgitation; TR, tricuspid regurgitation.